Does OLAPARIB Cause Hypersensitivity? 63 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Hypersensitivity have been filed in association with OLAPARIB (Lynparza). This represents 0.3% of all adverse event reports for OLAPARIB.
63
Reports of Hypersensitivity with OLAPARIB
0.3%
of all OLAPARIB reports
5
Deaths
16
Hospitalizations
How Dangerous Is Hypersensitivity From OLAPARIB?
Of the 63 reports, 5 (7.9%) resulted in death, 16 (25.4%) required hospitalization, and 3 (4.8%) were considered life-threatening.
Is Hypersensitivity Listed in the Official Label?
Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for OLAPARIB.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which OLAPARIB Alternatives Have Lower Hypersensitivity Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL